New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators

The F.D.A. recommends that clinical trial sponsors develop a Race and Ethnicity Diversity Plan to inform outreach, recruitment and retention throughout the trial process.